Tag Archives: Bio Therapeutic Medicine (TRBC level 5)

Australia asked the EU to review AstraZeneca vaccine blockages | Instant News


CANBERRA / TOKYO / BRUSSELS (Reuters) – Australia has asked the European Commission to review its decision to block shipments of the COVID-19 vaccine from AstraZeneca, as countries importing EU-made gunfire are concerned about the potential impact on supplies.

EU executives supported Italy’s decision to block the delivery of 250,000 doses of AstraZeneca vaccine to Australia, European officials said, in the first refusal of an export request since a mechanism to monitor vaccine flows was established in late January.

The move is a reaction to AstraZeneca’s delay in sending vaccines to the EU. The company said it could only supply about 40 million doses by the end of this month compared to the 90 million estimated in its contract.

An official said the Anglo-Swedish company initially asked Rome to deliver more doses to Australia, but then cut its demand to 250,000 following Italy’s first refusal, in which some of AstraZeneca’s COVID-19 vaccines were bottled.

“Australia has raised this issue with the European Commission through various channels, and in particular we have asked the European Commission to review this decision,” Australian Health Minister Greg Hunt told reporters in Melbourne.

A European Commission spokesman said on Friday that EU executives had not received a specific request from the Australian health minister about the vaccine block.

Hunt said Australia, which started the inoculation program two weeks ago, has received 300,000 doses of the AstraZeneca vaccine, which will last until local vaccine production increases. He added that the missing dose would not affect the rollout of Australia’s inoculation program.

When asked about the EU export ban, Japanese vaccine minister Taro Kono said: “We ask the Ministry of Foreign Affairs to thoroughly investigate. We want to work with the Ministry of Foreign Affairs to secure a vaccine for Japan. “

AstraZeneca did not reply to a request for comment.

FILE PHOTO: A test tube labeled “vaccine” in front of the AstraZeneca logo in this illustration taken, 9 September 2020. REUTERS / Dado Ruvic / Illustration

EXPORT CONTROLS

Despite the decision to block shipments to Australia, the EU has authorized all export requests from the debut scheme January 30 to March 1, totaling 174 requests for millions of shots to 29 countries, including Australia, Japan, Britain, the United Arab Emirates and Canada, the spokesperson said. talk to the European Union Commission.

Nearly all vaccines exported from the EU since late January have been manufactured by Pfizer and BioNTech, European Commission chief Ursula von der Leyen said last week, with much smaller quantities exported by Moderna and AstraZeneca.

The EU set up a mechanism to monitor vaccine exports after drug makers announced a suspension of their supply to the 27-nation block. It now plans to extend the scheme to the end of June after it ends on March 31, EU officials told Reuters.

When asked about Italy’s move, French Health Minister Olivier Veran said Paris could do the same, even though it is not currently producing a vaccine for COVID-19.

German Health Minister Jens Spahn said drug manufacturers must honor contracts for vaccine supply to Europe, but said Germany had no reason to stop sending domestically produced injections to other countries.

In seeking European Commission intervention, Australian Prime Minister Scott Morrison said he could understand the reasons for Italy’s objections.

“In Italy people are dying at a rate of 300 per day. So I can definitely understand the high level of anxiety that will be in Italy and in many countries across Europe, “Morrison told reporters in Sydney.

The Italian move comes just days after Prime Minister Mario Draghi, who took office last month, told fellow EU leaders the bloc needs to speed up vaccinations and crack down on pharmaceutical companies that fail to meet promised supplies.

EU countries started injections in late December, but moving at a much slower pace than other wealthy nations, including former members of the UK and the United States. Officials blamed the slow progress partly on supply problems with producers.

Reporting by Colin Packham in Canberra, Rocky Swift and Kiyoshi Takenaka in Tokyo, Sabine Siebold in Brussels; written by Colin Packham and Francesco Guarascio; Edited by Jane Wardell, Kenneth Maxwell and Nick Macfie

.



image source

A raging pandemic closes down on Sao Paulo as Brazil approaches the Pfizer deal | Instant News


SAO PAULO / RIO DE JANEIRO (Reuters) – Brazil set a daily record for COVID-19 deaths for the second day in a row on Wednesday, as the resurgence of a raging virus saw the state of Sao Paulo shut down businesses and the government tried to shut down a vaccine. dealing with Pfizer and Janssen.

FILE PHOTOS: General view of the Sao Paulo skyline April 2, 2015. REUTERS / Paulo Whitaker / Photo Files

With the new coronavirus variant from Amazon triggering more infections, according to the study, 1,910 people have died from the virus in the past 24 hours, according to Health Ministry data. Within a year, Brazil’s death toll was nearly 260,000, the second worst in the world after the United States.

A bogged down vaccination campaign also put pressure on Health Minister Eduardo Pazuello, who said on Wednesday he was close to reaching a deal with Pfizer Inc, effectively resolving a dispute over liability clauses.

The government said it would buy 100 million doses from Pfizer and 38 million from Janssen, a subsidiary of Johnson & Johnson pharmaceuticals.

“We have reached a moment of a severe pandemic. The coronavirus variant attacked us aggressively, ”Pazuello said in a video posted on social media, adding that he expected a dose of Pfizer to arrive in May.

In another video, he said the ministry was close to reaching a contract to receive Janssen’s “first grade” vaccine in August.

The partial lockdown in Sao Paulo, Brazil’s most populous state, underscores growing concerns about a new wave of infections. The country is facing its deadliest range since the pandemic began due to a local variant dubbed P1, rare restrictions on slowing down the virus and uneven vaccine rollouts.

Brazil set a record one-day death toll as the outbreak receded in North America and parts of Western Europe. That risks isolating Latin America’s largest country internationally as other countries seek to shore up their gains against the virus.

The Sao Paulo announcement, made by state governor João Doria, annoyed far-right President Jair Bolsonaro, who opposes the lockdown and has long sought to reduce the severity of the virus. But more states and cities are likely to follow in Sao Paulo’s footsteps as healthcare systems are pushed to their breaking point.

Bolsonaro struck lockdown again on Wednesday.

“You can’t panic, like once again turning to this stay-at-home policy. People will die of hunger and depression, “he told a group of supporters.

NEW RESTRICTIONS

From Saturday, Sao Paulo’s bars and restaurants will operate via delivery only, while malls and non-essential businesses will be closed, Doria said. The measures will take place in the last two weeks, he said, adding that the state was receiving new patients in intensive care units every two minutes.

Worse, questions remain about the suitability of Brazil’s vaccine portfolio – comprising the AstraZeneca injection, and other vaccines developed by China Sinovac Biotech Ltd – for the P1 variant.

Bolsonaro and other senior officials have publicly grumbled for weeks over Pfizer’s demands for a discharge of responsibility, saying the terms were unacceptable. Pfizer says many other countries have agreed on similar deals.

International fears are rising about the P1 variant, which emerged in the northern city of Manaus, and has since been identified around the world, leading to tougher regulations on Brazilian travelers.

The domestic situation is very critical. Blame increasingly landed on Bolsonaro’s lap.

Earlier this week, 16 Brazilian governors accused him of misleading the country. The national association of state health secretaries has also criticized the federal government, complaining of piecemeal approaches by individual states and cities, calling for a national curfew and airport closures.

Reporting by Eduardo Simoes, Pedro Fonseca, Ricardo Brito and Maria Carolina Marcello; Written by Gabriel Stargardter and Anthony Boadle; Edited by Peter Cooney

.



image source

A raging pandemic closes down on Sao Paulo as Brazil approaches the Pfizer deal | Instant News


SAO PAULO / RIO DE JANEIRO (Reuters) – Brazil set a daily record for COVID-19 deaths for the second day in a row on Wednesday, as the resurgence of a raging virus saw the state of Sao Paulo shut down businesses and the government tried to shut down a vaccine. dealing with Pfizer and Janssen.

FILE PHOTOS: General view of the Sao Paulo skyline April 2, 2015. REUTERS / Paulo Whitaker / Photo Files

With the new coronavirus variant from Amazon triggering more infections, according to the study, 1,910 people have died from the virus in the past 24 hours, according to Health Ministry data. Within a year, Brazil’s death toll was nearly 260,000, the second worst in the world after the United States.

A bogged down vaccination campaign also put pressure on Health Minister Eduardo Pazuello, who said on Wednesday he was close to reaching a deal with Pfizer Inc, effectively resolving a dispute over liability clauses.

The government said it would buy 100 million doses from Pfizer and 38 million from Janssen, a subsidiary of Johnson & Johnson pharmaceuticals.

“We have reached a moment of a severe pandemic. The coronavirus variant attacked us aggressively, ”Pazuello said in a video posted on social media, adding that he expected a dose of Pfizer to arrive in May.

In another video, he said the ministry was close to reaching a contract to receive Janssen’s “first grade” vaccine in August.

The partial lockdown in Sao Paulo, Brazil’s most populous state, underscores growing concerns about a new wave of infections. The country is facing its deadliest range since the pandemic began due to a local variant dubbed P1, rare restrictions on slowing down the virus and uneven vaccine rollouts.

Brazil set a record one-day death toll as the outbreak receded in North America and parts of Western Europe. That risks isolating Latin America’s largest country internationally as other countries seek to shore up their gains against the virus.

The Sao Paulo announcement, made by state governor João Doria, annoyed far-right President Jair Bolsonaro, who opposes the lockdown and has long sought to reduce the severity of the virus. But more states and cities are likely to follow in Sao Paulo’s footsteps as healthcare systems are pushed to their breaking point.

Bolsonaro struck lockdown again on Wednesday.

“You can’t panic, like once again turning to this stay-at-home policy. People will die of hunger and depression, “he told a group of supporters.

NEW RESTRICTIONS

From Saturday, Sao Paulo’s bars and restaurants will operate via delivery only, while malls and non-essential businesses will be closed, Doria said. The measures will take place in the last two weeks, he said, adding that the state was receiving new patients in intensive care units every two minutes.

Worse, questions remain about the suitability of Brazil’s vaccine portfolio – comprising the AstraZeneca injection, and other vaccines developed by China Sinovac Biotech Ltd – for the P1 variant.

Bolsonaro and other senior officials have publicly grumbled for weeks over Pfizer’s demands for a discharge of responsibility, saying the terms were unacceptable. Pfizer says many other countries have agreed on similar deals.

International fears are rising about the P1 variant, which emerged in the northern city of Manaus, and has since been identified around the world, leading to tougher regulations on Brazilian travelers.

The domestic situation is very critical. Blame increasingly landed on Bolsonaro’s lap.

Earlier this week, 16 Brazilian governors accused him of misleading the country. The national association of state health secretaries has also criticized the federal government, complaining of piecemeal approaches by individual states and cities, calling for a national curfew and airport closures.

Reporting by Eduardo Simoes, Pedro Fonseca, Ricardo Brito and Maria Carolina Marcello; Written by Gabriel Stargardter and Anthony Boadle; Edited by Peter Cooney

.



image source

Italy could mass produce a vaccine in 4-6 months: service | Instant News


FILE PHOTO: A medical worker holds a COVID-19 vaccine bottle at a newly opened mass vaccination center at the Cecchignola military complex, in Rome, Italy, February 23, 2021. REUTERS / Remo Casilli

MILAN (Reuters) – Several Italian companies have given their availability to produce the COVID-19 vaccine and production could take off in 4-6 months after regulatory authorization, the industry ministry said on Wednesday.

Many companies will be ready to manufacture bulk drug substances – the active ingredients of vaccines – “because they already have, or will soon have, the necessary bioreactors and fermentation equipment,” the statement said.

He added that the government is willing to set up a research center in Italy for COVID-19 drugs and vaccines, which are financed by public and private investment.

Report by Giuseppe Fonte, by Maria Pia Quaglia, editing by Giulia Segreti

.



image source

Brazil approved Pfizer’s COVID-19 shots, but none of them worked | Instant News


FILE PHOTOS: Pfizer-BioNTech vaccine bottle pictured at a vaccination center in Geneva, Switzerland, February 3, 2021. REUTERS / Denis Balibouse

SAO PAULO (Reuters) – Brazil has fully approved the COVID-19 vaccine developed by Pfizer Inc and BioNTech SE, its health regulators said on Tuesday, although disagreements over a supply deal mean neither side can initiate an immunization program.

This is the first coronavirus injection to receive full approval in Brazil, said regulator Anvisa. The vaccine, developed by AstraZeneca and China Sinovac Biotech Ltd, is only approved for emergency use.

The agreement is good news for a country whose immunization campaign has been plagued by delays and political bickering. However, it is unclear if this will pave the way for a supply deal for the highly effective shoots that are being rolled out globally.

“We look forward to moving forward in our negotiations with the Brazilian government to support immunization of the country’s population,” said Pfizer Brazil boss Marta Diez in a statement, without providing further details.

Brazil’s Ministry of Health did not respond to a request for comment.

President Jair Bolsonaro has criticized the terms of the deal proposed by Pfizer, saying the deal was too burdensome because it freed US companies from potential liability for unforeseen problems. Pfizer said other countries, including Brazil’s Latin American neighbors, have agreed to the terms.

Reporting by Eduardo Simoes. Written by Gabriel Stargardter. Edited by Mark Potter and John Stonestreet

.



image source